IJCS | Volume 32, Nº5, September/October 2019

504 valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47(6):1214-23. 9. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-607. 10. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators .Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-98. 11. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS,et al; PARTNER Trial Investigators.Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012; 366(18):1696-704. 12. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al; U.S. CoreValve Clinical Investigators. Transcatheter aortic- valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-8. 13. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR ,et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(13):1200-54 14. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P,et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50(1):69-76. 15. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V,et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12(5):762-7. 16. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G,et al. Transcatheter aortic valve implantation: early results of the France (French Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32(2):191-7. 17. Akin I, Kische S, Parankaya L, Schneider H, Rehders TC, Trautwein U,et al. Predictive factors for pacemaker requirement after transcatheter aortic valve implantation. BMC Cardiovasc Disord. 2012 Oct;12:87. 18. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8536 patients. Catheter Cardiovasc Interv. 2012; 80(1):128–38. 19. Siontis GC, Juni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129–40 20. Hasan Basri E, Nihan K, Hasan A, Omeroglu SN, Kirali K, Guler M, et al. Risk factors for requirement of permanent pacemaker implantation after aortic valve replacement. J Cardiac Surg. 2006;21(3):211-5 21. Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS,et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart. 2015;101(20):1655-71. 22. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1(3):310-6. 23. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP,et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S126–30. 24. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, et al. Incidence, predictors, and outcomes of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011;107(5):747-54. 25. Houthuizen P, Van Garsse LA, PoelsTT, de Jaegere P, van der Boon RM, SwinkelsBM,etal.Leftbundle-branchblockinducedbytranscatheteraortic valve implantation increases risk of death. Circulation. 2012;126(6):720-8. 26. Testa L, Latib A, De Marco F, De Carlo M, Agnifili M, Latini RA,et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantationwith CoreValve Revalving System. Circulation. 2013;127(12):1300-7 27. UrenaM, MokM, SerraV, Dumont E, Nombela-Franco L, DeLarochellière R,et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol. 2012;60(18):1743-52 28. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation(EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9-13 29. Guimaraes JI, Nicolau JC, Polanczyk CA, et al. Diretrizes de interpretação de eletrocardiograma de repouso. Arq Bras Cardiol. 2003;80(Suppl 2):1-63. 30. European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA),Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2013;15(8):1070-118. 31. Martinelli Filho M, Zimerman LI, Lorga AM, Vasconcelos JTM, Rassi A Jr. Guidelines for Implantable Electronic Cardiac Devices of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2007;89(6):e210-e238. 32. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1(1):78-81. 33. Moreno R, Dobarro D, Lopéz de Sá E, Prieto M, Morales C, Calvo Orbe L, et al. Cause of complete atrioventicular block after percutaneous aortic valve implantation. Insights from a necropsy study. Circulation. 2009;120(5):e29-30 34. Martinez-Selles M, Bramlage P, Thoenes M, Schymik G. Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol. 2015;104(1):1-12 35. Aktug O, Dohmen G, Brehmer K, Koos R, Altiok E, Deserno V, et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol. 2012;160(1):26-30. 36. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, et al. Permanent pacemaker insertion after Corevalve Transcatheter aortic valve implantation. Circulation. 2011;123(9):951-96. 37. De Carlo M, Giannini C, Bedogni F, Klugmann S, Brambilla N, De Marco F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J. 2012;163(3):492-9. 38. Bleiziffer S, Ruge H, Horer J, Klugmann S, Brambilla N, De Marco F, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(5):524–30. 39. Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, et al. Conduction disturbances after transcatheter aortic valve replacement. Circulation. 2017;136(11):1049-69. 40. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H ,et al. Dual chamber and VVI implantable defibrillator trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The DAVID trial. JAMA. 2002;228(24):3115-23. Cedenilla et al. Requirements for permanent pacemaker afterTAVI Int J Cardiovasc Sci. 2019;32(5):492-504 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License